These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 2671143)
1. The quinolones. Neu HC Infect Dis Clin North Am; 1989 Sep; 3(3):625-39. PubMed ID: 2671143 [TBL] [Abstract][Full Text] [Related]
2. [Quinolones: confirmations and promises]. De Marino V; Marino A Clin Ter; 1990 Jan; 132(1):3-11. PubMed ID: 2139369 [TBL] [Abstract][Full Text] [Related]
3. [Quinolones: new synthetic antimicrobial agents]. Lopes HV AMB Rev Assoc Med Bras; 1988; 34(2):54-60. PubMed ID: 3072599 [No Abstract] [Full Text] [Related]
4. The place of quinolones in bacterial infections. Neu HC Adv Intern Med; 1991; 36():1-32. PubMed ID: 2024577 [TBL] [Abstract][Full Text] [Related]
5. Quinolones: which generation for which microbe? Lee MK; Kanatani MS West J Med; 1999 Jun; 170(6):359-61. PubMed ID: 10443165 [No Abstract] [Full Text] [Related]
6. Microbiologic aspects of fluoroquinolones. Neu HC Am J Ophthalmol; 1991 Oct; 112(4 Suppl):15S-24S. PubMed ID: 1928268 [TBL] [Abstract][Full Text] [Related]
7. [The new quinolones]. Lontie M J Pharm Belg; 1989; 44(4):292-301. PubMed ID: 2691640 [TBL] [Abstract][Full Text] [Related]
8. Overview of the fluoroquinolone antibiotics. Just PM Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356 [TBL] [Abstract][Full Text] [Related]
9. Quinolone antimicrobial agents. Neu HC Annu Rev Med; 1992; 43():465-86. PubMed ID: 1580602 [TBL] [Abstract][Full Text] [Related]
10. [In vitro evaluation of lomefloxacin]. Dette GA; Knothe H Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672 [TBL] [Abstract][Full Text] [Related]
12. In vitro activities of three nonfluorinated quinolones against representative bacterial isolates. Barry AL; Fuchs PC; Brown SD Antimicrob Agents Chemother; 2001 Jun; 45(6):1923-7. PubMed ID: 11353655 [TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones: how to use (but not overuse) these antibiotics. Sable CA; Scheld WM Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of fluoroquinolones against gram-positive bacteria. Bush K; Goldschmidt R Curr Opin Investig Drugs; 2000 Sep; 1(1):22-30. PubMed ID: 11249591 [TBL] [Abstract][Full Text] [Related]
15. Quinolones: a practical review of clinical uses, dosing considerations, and drug interactions. Borcherding SM; Stevens R; Nicholas RA; Corley CR; Self T J Fam Pract; 1996 Jan; 42(1):69-78. PubMed ID: 8537808 [TBL] [Abstract][Full Text] [Related]
16. [Quinolones]. Lode H Schweiz Med Wochenschr; 1988 Dec; 118(49):1823-30. PubMed ID: 3064290 [TBL] [Abstract][Full Text] [Related]
17. The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients. Rolston KV; Yadegarynia D; Kontoyiannis DP; Raad II; Ho DH Int J Infect Dis; 2006 May; 10(3):223-30. PubMed ID: 16439177 [TBL] [Abstract][Full Text] [Related]
18. Sparfloxacin and other new fluoroquinolones. Richard P; Gutmann L J Antimicrob Chemother; 1992 Dec; 30(6):739-44. PubMed ID: 1337749 [No Abstract] [Full Text] [Related]
19. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates. Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230 [TBL] [Abstract][Full Text] [Related]
20. Enrofloxacin: a new antimicrobial agent. Schroder J J S Afr Vet Assoc; 1989 Jun; 60(2):122-4. PubMed ID: 2691696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]